NGFR | Nerve growth factor receptor | Cancer-related genes CD markers Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
NRAS | Neuroblastoma RAS viral (v-ras) oncogene homolog | Cancer-related genes Disease related genes RAS pathway related proteins
| | | | | Expressed in all |
PAK1 | P21 protein (Cdc42/Rac)-activated kinase 1 | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK2 | P21 protein (Cdc42/Rac)-activated kinase 2 | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK3 | P21 protein (Cdc42/Rac)-activated kinase 3 | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Tissue enhanced |
PAK4 | P21 protein (Cdc42/Rac)-activated kinase 4 | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PAK6 | P21 protein (Cdc42/Rac)-activated kinase 6 | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Mixed |
PAK7 | P21 protein (Cdc42/Rac)-activated kinase 7 | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PDGFA | Platelet-derived growth factor alpha polypeptide | Cancer-related genes Candidate cardiovascular disease genes Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PDGFB | Platelet-derived growth factor beta polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PDGFC | Platelet derived growth factor C | Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
PDGFD | Platelet derived growth factor D | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PGF | Placental growth factor | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
PIK3CB | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PIK3CD | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Mixed |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PIK3R3 | Phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | Cancer-related genes RAS pathway related proteins
| | | | | Tissue enhanced |
PIK3R5 | Phosphoinositide-3-kinase, regulatory subunit 5 | Disease related genes RAS pathway related proteins
| | | | | Tissue enhanced |
PLA1A | Phospholipase A1 member A | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2G10 | Phospholipase A2, group X | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2G12A | Phospholipase A2, group XIIA | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PLA2G16 | Phospholipase A2, group XVI | Enzymes Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
PLA2G2A | Phospholipase A2, group IIA (platelets, synovial fluid) | Enzymes FDA approved drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2G2D | Phospholipase A2, group IID | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PLA2G2E | Phospholipase A2, group IIE | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Not detected |
PLA2G3 | Phospholipase A2, group III | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PLA2G4A | Phospholipase A2, group IVA (cytosolic, calcium-dependent) | Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
PLA2G4B | Phospholipase A2, group IVB (cytosolic) | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PLA2G4C | Phospholipase A2, group IVC (cytosolic, calcium-independent) | Enzymes RAS pathway related proteins
| | | | | Mixed |
PLA2G4D | Phospholipase A2, group IVD (cytosolic) | Enzymes RAS pathway related proteins
| | | | | Group enriched |
PLA2G4E | Phospholipase A2, group IVE | RAS pathway related proteins
| | | | | Tissue enriched |
PLA2G4F | Phospholipase A2, group IVF | Enzymes RAS pathway related proteins
| | | | | Group enriched |
PLA2G5 | Phospholipase A2, group V | Disease related genes Enzymes Potential drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2G6 | Phospholipase A2, group VI (cytosolic, calcium-independent) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
PLCE1 | Phospholipase C, epsilon 1 | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
PLCG1 | Phospholipase C, gamma 1 | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PLCG2 | Phospholipase C, gamma 2 (phosphatidylinositol-specific) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
PLD1 | Phospholipase D1, phosphatidylcholine-specific | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PLD2 | Phospholipase D2 | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKACA | Protein kinase, cAMP-dependent, catalytic, alpha | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKACB | Protein kinase, cAMP-dependent, catalytic, beta | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKACG | Protein kinase, cAMP-dependent, catalytic, gamma | Enzymes RAS pathway related proteins
| | | | | Tissue enriched |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKCB | Protein kinase C, beta | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PRKCG | Protein kinase C, gamma | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Tissue enriched |